EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search

XPH

SPDR® S&P Pharmaceuticals ETF

NYSE ARCAETF
$67.16
+1.13%today

No SEC filings for this security

SPDR® S&P Pharmaceuticals ETF is a foreign or OTC-listed security (NYSE ARCA) that doesn't file with the SEC, so the grounded research view — financials, filings, insider activity and the call — isn't available. Price and news only.

Key stats

52-week range$40.80 – $67.16
40.8052-week67.16
Market cap
$259M
Volume
87.1K
1Y return
+66.19%
Beta
0.00

Price · 1Y

$67.16▲ +66.19%
over 1Y
L $40.36H $67.16

Recent news

market news →
SPDR S&P Pharmaceuticals ETF declares quarterly distribution of $0.0590Bullish
seekingalpha.com· 2026-06-22
State Street SPDR S&P Pharmaceuticals vs First Trust NYSE Arca Biotech: Which Is the Better ETF For Your Portfolio?Bullish
finance.yahoo.com· 2026-06-04
Biotech ETFs: Which ETF Offers Lower Fees? IBBQ or XPH?Bullish
finance.yahoo.com· 2026-06-04
Biotech ETFs: Which ETF Offers Lower Fees? IBBQ or XPH?Bullish
nasdaq.com· 2026-06-04
US Customs processing $20.6B in importer tariff refunds: reportBullish
seekingalpha.com· 2026-05-27
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?Bullish
nasdaq.com· 2026-04-03
No deal yet? Trump readies new tariffs on select drugmakers - reportBullish
seekingalpha.com· 2026-04-02
XPH’s 29% Run Looks Tempting, But The 5y Chart Is A WarningBullish
finance.yahoo.com· 2026-02-18

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.